Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Twenty years experience in treating childhood medulloblastoma: Between the past and the present.

Khalil J, Qing Z, Chuanying Z, Belkacémi Y, Benjaafar N, Mawei J.

Cancer Radiother. 2019 Jun;23(3):179-187. doi: 10.1016/j.canrad.2018.05.008. Epub 2019 May 18.

PMID:
31109839
2.
3.

Primary postoperative chemotherapy without radiotherapy for treatment of brain tumours other than ependymoma in children under 3 years: results of the first UKCCSG/SIOP CNS 9204 trial.

Grundy RG, Wilne SH, Robinson KJ, Ironside JW, Cox T, Chong WK, Michalski A, Campbell RH, Bailey CC, Thorp N, Pizer B, Punt J, Walker DA, Ellison DW, Machin D; Children's Cancer and Leukaemia Group (formerly UKCCSG) Brain Tumour Committee.

Eur J Cancer. 2010 Jan;46(1):120-33. doi: 10.1016/j.ejca.2009.09.013.

PMID:
19818598
4.

Adult medulloblastoma: multiagent chemotherapy.

Greenberg HS, Chamberlain MC, Glantz MJ, Wang S.

Neuro Oncol. 2001 Jan;3(1):29-34. doi: 10.1093/neuonc/3.1.29. Review.

5.

Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trial.

Robinson GW, Rudneva VA, Buchhalter I, Billups CA, Waszak SM, Smith KS, Bowers DC, Bendel A, Fisher PG, Partap S, Crawford JR, Hassall T, Indelicato DJ, Boop F, Klimo P, Sabin ND, Patay Z, Merchant TE, Stewart CF, Orr BA, Korbel JO, Jones DTW, Sharma T, Lichter P, Kool M, Korshunov A, Pfister SM, Gilbertson RJ, Sanders RP, Onar-Thomas A, Ellison DW, Gajjar A, Northcott PA.

Lancet Oncol. 2018 Jun;19(6):768-784. doi: 10.1016/S1470-2045(18)30204-3. Epub 2018 May 16.

6.

[Medulloblastoma: improved survival in recent decades. Unicentric experience].

Igual Estellés L, Berlanga Charriel P, Cañete Nieto A.

An Pediatr (Barc). 2017 Jan;86(1):4-10. doi: 10.1016/j.anpedi.2016.03.004. Epub 2016 Apr 8. Spanish.

7.

Long-term toxic effects of proton radiotherapy for paediatric medulloblastoma: a phase 2 single-arm study.

Yock TI, Yeap BY, Ebb DH, Weyman E, Eaton BR, Sherry NA, Jones RM, MacDonald SM, Pulsifer MB, Lavally B, Abrams AN, Huang MS, Marcus KJ, Tarbell NJ.

Lancet Oncol. 2016 Mar;17(3):287-98. doi: 10.1016/S1470-2045(15)00167-9. Epub 2016 Jan 30.

PMID:
26830377
8.

Late toxicity following craniospinal radiation for early-stage medulloblastoma.

Christopherson KM, Rotondo RL, Bradley JA, Pincus DW, Wynn TT, Fort JA, Morris CG, Mendenhall NP, Marcus RB Jr, Indelicato DJ.

Acta Oncol. 2014 Apr;53(4):471-80. doi: 10.3109/0284186X.2013.862596. Epub 2014 Feb 24.

PMID:
24564687
9.

Primary spinal glioma in children: Results from a referral pediatric institution in Shanghai.

Khalil J, Chuanying Z, Qing Z, Belkacémi Y, Mawei J.

Cancer Radiother. 2017 Jun;21(4):261-266. doi: 10.1016/j.canrad.2016.11.005. Epub 2017 May 16.

PMID:
28522280
10.

Chemotherapy for children with medulloblastoma.

Michiels EM, Schouten-Van Meeteren AY, Doz F, Janssens GO, van Dalen EC.

Cochrane Database Syst Rev. 2015 Jan 1;1:CD006678. doi: 10.1002/14651858.CD006678.pub2. Review.

PMID:
25879092
11.

Outcome for children with medulloblastoma treated with radiation and cisplatin, CCNU, and vincristine chemotherapy.

Packer RJ, Sutton LN, Elterman R, Lange B, Goldwein J, Nicholson HS, Mulne L, Boyett J, D'Angio G, Wechsler-Jentzsch K, et al.

J Neurosurg. 1994 Nov;81(5):690-8.

PMID:
7931615
12.

Italian cancer figures, report 2012: Cancer in children and adolescents.

AIRTUM Working Group; CCM; AIEOP Working Group.

Epidemiol Prev. 2013 Jan-Feb;37(1 Suppl 1):1-225. English, Italian.

13.

[Craniospinal radiotherapy in combined therapy of medulloblastoma in children and adolescents].

Golubicić I, Bokun J, Nikitović M, Mladenović J, Sarić M, Bekić Z.

Srp Arh Celok Lek. 2003 May-Jun;131(5-6):226-31. Serbian.

14.

Medulloblastoma: conventional radiation therapy in comparison to chemo radiation therapy in the post-operative treatment of high-risk patients.

Abd El-Aal HH, Mokhtar MM, Habib E, El-Kashef AT, Fahmy ES.

J Egypt Natl Canc Inst. 2005 Dec;17(4):301-7.

15.

Prognostic effect of whole chromosomal aberration signatures in standard-risk, non-WNT/non-SHH medulloblastoma: a retrospective, molecular analysis of the HIT-SIOP PNET 4 trial.

Goschzik T, Schwalbe EC, Hicks D, Smith A, Zur Muehlen A, Figarella-Branger D, Doz F, Rutkowski S, Lannering B, Pietsch T, Clifford SC.

Lancet Oncol. 2018 Dec;19(12):1602-1616. doi: 10.1016/S1470-2045(18)30532-1. Epub 2018 Nov 1.

16.

Clinical characteristics and abandonment and outcome of treatment in 67 Chinese children with medulloblastoma.

Wang C, Yuan XJ, Jiang MW, Wang LF.

J Neurosurg Pediatr. 2016 Jan;17(1):49-56. doi: 10.3171/2015.5.PEDS1573. Epub 2015 Oct 9.

PMID:
26451721
17.

Endocrine sequelae beyond 10 years in survivors of medulloblastoma.

Uday S, Murray RD, Picton S, Chumas P, Raju M, Chandwani M, Alvi S.

Clin Endocrinol (Oxf). 2015 Nov;83(5):663-70. doi: 10.1111/cen.12815. Epub 2015 Jun 24.

PMID:
25952583
18.

Survival and prognostic factors in a series of adults with medulloblastomas.

Riffaud L, Saikali S, Leray E, Hamlat A, Haegelen C, Vauleon E, Lesimple T.

J Neurosurg. 2009 Sep;111(3):478-87. doi: 10.3171/2009.1.JNS081004.

PMID:
19231932
19.

Local control in non-metastatic medulloblastoma.

Christopherson KM, Bradley JA, Rotondo RL, Pincus DW, Fort JA, Morris CG, Mendenhall NP, Marcus RB Jr, Indelicato DJ.

Acta Oncol. 2014 Sep;53(9):1151-7. doi: 10.3109/0284186X.2014.932434. Epub 2014 Jul 3.

PMID:
24991891
20.

Proton radiation therapy for pediatric medulloblastoma and supratentorial primitive neuroectodermal tumors: outcomes for very young children treated with upfront chemotherapy.

Jimenez RB, Sethi R, Depauw N, Pulsifer MB, Adams J, McBride SM, Ebb D, Fullerton BC, Tarbell NJ, Yock TI, Macdonald SM.

Int J Radiat Oncol Biol Phys. 2013 Sep 1;87(1):120-6. doi: 10.1016/j.ijrobp.2013.05.017. Epub 2013 Jun 21.

PMID:
23790826

Supplemental Content

Support Center